Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition. [electronic resource]
Producer: 20161213Description: 21 p. digitalISSN:- 1534-6269
- Antibodies -- immunology
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- B7-H1 Antigen -- blood
- Biomarkers, Tumor -- blood
- CTLA-4 Antigen -- blood
- Humans
- Immunotherapy
- Ipilimumab
- Melanoma -- blood
- Nivolumab
- Programmed Cell Death 1 Receptor -- blood
- Tumor Microenvironment -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.